Cyrus Biotechnology

Biotechnology ResearchWashington, United States11-50 Employees

Cyrus Biotechnology is a pre-clinical biotech company focused on designing and screening novel protein therapeutics to address serious unmet medical needs. By combining protein design with screening, the company aims to develop an early pipeline of innovative programs across multiple indications and engage in collaborations that advance discovery toward the clinic. The firm operates from Seattle, Washington, and draws on core software developed in the lab of David Baker at the University of Washington, reflecting its origins in university-led protein engineering research. Cyrus partners with other biotech and pharma entities and research institutes to bring collaborative programs forward, leveraging external expertise to broaden its discovery efforts.

With a presence in the biotechnology research sector, Cyrus positions itself at the intersection of computational design and biologics development. Its activities center on creating engineered therapeutic proteins, including tools for antibody structure prediction, and pursuing partnerships that extend its reach beyond internal programs. The company situates itself among peers in biotech darker to broader therapeutic protein design and collaboration-driven development, seeking to translate computational design into clinically relevant biologics while maintaining a focus on autoimmune and immune-related indications as highlighted by its past collaborations.

Sign up for free to view info

Email Format Employee directory